FilingSEC EDGAR8-K
Milestone Pharmaceuticals Receives Nasdaq Deficiency Notice
· SEC accepted
StageListing Warning
Filing content
The company received a notice from Nasdaq for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days, with a compliance period granted until April 21, 2027.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…